Lennard A - Search Results

1

Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfa.

Marin D, Marktel S, Bua M, Szydlo RM, Franceschino A, Nathan I, Foot N, Crawley C, Na Nakorn T, Olavarria E, Lennard A, Neylon A, O'Brien SG, Goldman JM, Apperley JF. Marin D, et al. Among authors: lennard a. Leukemia. 2003 Aug;17(8):1448-53. doi: 10.1038/sj.leu.2402996. Leukemia. 2003. PMID: 12886230

2

Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia.

Olavarria E, Siddique S, Griffiths MJ, Avery S, Byrne JL, Piper KP, Lennard AL, Pallan L, Arrazi JM, Perz JB, O'Shea D, Goldman JM, Apperley JF, Craddock CF. Olavarria E, et al. Blood. 2007 Dec 15;110(13):4614-7. doi: 10.1182/blood-2007-04-082990. Epub 2007 Sep 19. Blood. 2007. PMID: 17881635 Free article. Clinical Trial.

3

Mobilization of Ph chromosome-negative peripheral blood stem cells in chronic myeloid leukaemia patients with imatinib mesylate-induced complete cytogenetic remission.

Drummond MW, Marin D, Clark RE, Byrne JL, Holyoake TL, Lennard A; United Kingdom Chronic Myeloid Leukaemia (UK CML) Working Party. Drummond MW, et al. Among authors: lennard a. Br J Haematol. 2003 Nov;123(3):479-83. doi: 10.1046/j.1365-2141.2003.04599.x. Br J Haematol. 2003. PMID: 14617010 Free article.

4

Collection of Philadelphia-negative peripheral blood progenitor cells in unselected patients with chronic granulocytic leukaemia. Northern Regional Haematology Group.

Lennard A, Storey N, Dickinson AM, Irving JA, Rowe D, Conn JS, Proctor SJ. Lennard A, et al. Leukemia. 1998 May;12(5):746-52. doi: 10.1038/sj.leu.2400993. Leukemia. 1998. PMID: 9593273 Clinical Trial.

5

Analysis of CD34 populations in mobilised peripheral blood stem cell harvests and in bone marrow by fluorescent in situ hybridisation for the bcr/abl gene fusion in patients with chronic granulocytic leukaemia.

Irving JA, Lennard A, Storey N, Conn J, Dunn J, Oliver K, Proctor SJ, Dickinson AM. Irving JA, et al. Among authors: lennard a. Leukemia. 1999 Jun;13(6):944-9. doi: 10.1038/sj.leu.2401435. Leukemia. 1999. PMID: 10360384

6

Telomere shortening correlates with prognostic score at diagnosis and proceeds rapidly during progression of chronic myeloid leukemia.

Drummond M, Lennard A, Brûmmendorf T, Holyoake T. Drummond M, et al. Among authors: lennard a. Leuk Lymphoma. 2004 Sep;45(9):1775-81. doi: 10.1080/10428190410001693542. Leuk Lymphoma. 2004. PMID: 15223635

7

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study.

Talpaz M, Silver RT, Druker BJ, Goldman JM, Gambacorti-Passerini C, Guilhot F, Schiffer CA, Fischer T, Deininger MW, Lennard AL, Hochhaus A, Ottmann OG, Gratwohl A, Baccarani M, Stone R, Tura S, Mahon FX, Fernandes-Reese S, Gathmann I, Capdeville R, Kantarjian HM, Sawyers CL. Talpaz M, et al. Among authors: lennard al. Blood. 2002 Mar 15;99(6):1928-37. doi: 10.1182/blood.v99.6.1928. Blood. 2002. PMID: 11877262 Free article. Clinical Trial.

8

Use of denaturing HPLC for detection of mutations in the BCR-ABL kinase domain in patients resistant to Imatinib.

Irving JA, O'Brien S, Lennard AL, Minto L, Lin F, Hall AG. Irving JA, et al. Among authors: lennard al. Clin Chem. 2004 Jul;50(7):1233-7. doi: 10.1373/clinchem.2004.034801. Clin Chem. 2004. PMID: 15229152 No abstract available.

9

Low incidence of myelodysplastic syndrome following transplantation using autologous non-cryopreserved bone marrow.

Taylor PR, Jackson GH, Lennard AL, Hamilton PJ, Proctor SJ. Taylor PR, et al. Among authors: lennard al. Leukemia. 1997 Oct;11(10):1650-3. doi: 10.1038/sj.leu.2400795. Leukemia. 1997. PMID: 9324284

10

Hydroxyurea-induced acute alveolitis in a patient with chronic myeloid leukaemia.

Jackson GH, Wallis J, Ledingham J, Lennard A, Proctor SJ. Jackson GH, et al. Among authors: lennard a. Cancer Chemother Pharmacol. 1990;27(2):168-9. doi: 10.1007/BF00689105. Cancer Chemother Pharmacol. 1990. PMID: 2249336

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters